ZYME (STOCKS)
Zymeworks Inc.
$26.260000
-0.060000 (-0.23%)
Prev close: $26.320000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Kenneth Harry Galbraith
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,942.96M
- Employees
- 273
- P/E (TTM)
- -24.25
- P/B (TTM)
- 7.37
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $31.62M |
| Benefits Costs and Expenses | $269.29M |
| Costs And Expenses | $271.95M |
| Nonoperating Income/Loss | $2.02M |
| Operating Expenses | $271.95M |
| Research and Development | $223.29M |
| Other Operating Expenses | $48.66M |
| Operating Income/Loss | -$240.32M |
| Income/Loss From Continuing Operations After Tax | -$236.98M |
| Income/Loss From Continuing Operations Before Tax | -$237.67M |
| Income Tax Expense/Benefit | -$690.00K |
| Net Income/Loss | -$236.98M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$236.98M |
| Net Income/Loss Available To Common Stockholders, Basic | -$236.98M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.08 |
| Diluted Earnings Per Share | -$4.36 |
| Basic Average Shares | 179,448,459 |
| Diluted Average Shares | 179,977,522 |
| Assets | $368.97M |
| Current Assets | $263.07M |
| Noncurrent Assets | $105.90M |
| Fixed Assets | $26.16M |
| Non-current Prepaid Expenses | $16.08M |
| Other Non-current Assets | $63.67M |
| Liabilities | $146.69M |
| Current Liabilities | $80.09M |
| Wages | $8.29M |
| Other Current Liabilities | $71.80M |
| Noncurrent Liabilities | $66.60M |
| Equity | $222.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $222.28M |
| Liabilities And Equity | $368.97M |
| Net Cash Flow From Operating Activities | -$211.53M |
| Net Cash Flow From Operating Activities, Continuing | -$211.53M |
| Net Cash Flow From Investing Activities | $39.15M |
| Net Cash Flow From Investing Activities, Continuing | $39.15M |
| Net Cash Flow From Financing Activities | $113.57M |
| Net Cash Flow From Financing Activities, Continuing | $113.57M |
| Exchange Gains/Losses | $303.00K |
| Net Cash Flow | -$58.51M |
| Net Cash Flow, Continuing | -$58.81M |
| Comprehensive Income/Loss | -$236.98M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$236.98M |
| Other Comprehensive Income/Loss | $47.49M |